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                                          ABSTRACT: 
BACK GROUND : 
    Leprosy is a chronic granulomatous disease caused by Mycobacterium 
leprae. The introduction of Multidrug therapy in the year 1983 has reduced the 
prevalence of leprosy in Tamil Nadu from 118/10,000 in 1983 to less than 
10/10,000 in 1994.   
   
 Leprosy was declared eliminated on January 2006, since the prevalence 
reached the level below 1/10000 population in India. As per latest National 
Leprosy Eradication Programme data available only 1.35 lakh new cases were 
reported in India during the Year 2012-2013.But several reports from Himachal 
Pradesh and Maharashtra had indicated that leprosy case load may be many folds 
higher in India and elsewhere than is being reported under respective government 
health systems.  
 
Aims and objectives: 
 
a. To assess the incidence and prevalence of leprosy in Alanganallur block of 
Madurai district through door to door survey. 
 To compare Government data which reflects the voluntarily reported cases with 
this survey to see whether there is any undetected cases of leprosy and hence under 
reporting in Health system. 
 Methodology: 
The survey was  conducted with the help of 25 Accredited Social Health 
Activist (ASHA) their work was  supervised by Health inspectors, Non medical 
supervisors and Investigator. These ASHA workers were trained to  do house to 
house survey in their villages to identify suspected  cases of leprosy, leprosy-
related disability and complications and old cases using verbal questionnaire. I the 
Investigator, examined these suspects to filter out non leprosy cases and the 
leprosy cases were confirmed by a thorough clinical examination, slit skin smear 
and biopsy when necessary.    
  
                               There is a large backlog in the detection of leprosy cases in the 
endemic areas. There are also problems faced by patients in accessing the state 
healthcare facilities. This warrants the need for active surveillance in the 
community to attain the actual elimination 
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Introduction: 
Leprosy is a chronic granulomatous disease caused by 
Mycobacterium leprae. The introduction of Multidrug therapy in the year 
1983 has reduced the prevalence of leprosy in Tamil Nadu from 
118/10,000 in 1983 to less than 10/10,000 in 1994.   
   
Public Health Department conducted cost-analysis study of the 
National Leprosy Eradication Programme (NLEP) and concluded that the 
vertical programme was no longer cost-effective. Based on this report, in 
July 1997 Tamil Nadu was the first state in India, to integrate NLEP with 
the Primary Health Care system. 
 
Leprosy was declared eliminated on January 2006, since the 
prevalence reached the level below 1/10000 population in India. As per 
latest National Leprosy Eradication Programme data available only 1.35 
lakh new cases were reported in India during the Year 2012-2013.But 
several reports from Himachal Pradesh and Maharashtra had indicated 
that leprosy case load may be many folds higher in India and elsewhere 
than is being reported under respective government health systems.  
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This has created doubts about actual achievements in leprosy control. 
Hence this study was undertaken to perform door to door survey at 
Alanganallur block which is identified to have higher Annual New Case 
Detection Rate than State and National averages for past 2 years. 
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Aims and objectives: 
 
a. To assess the incidence and prevalence of leprosy in Alanganallur 
block of Madurai district through door to door survey. 
 
b. To compare Government data which reflects the voluntarily 
reported cases with this survey to see whether there is any 
undetected cases of leprosy and hence under reporting in Health 
system. 
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History of leprosy 
The word ‘Lepra’ indicates any disease which produces scaly skin 
lesions. Daniel Cornelius Danielson and Carl Wilhelm Boeck, researchers 
of Norway, classified leprosy into two types, Elephantiasis Graecorum 
Tuberosa and Elepantiasis anesthetosa. In India leprosy has been 
mentioned in Vedic period. Leper means most sinful person. 
Indian physician Dr. Gopala Krishna did a comprehensive work 
and prescribed ‘galita kushtari rasa’ for treatment of leprosy. 
         Norwegian medical society appointed Hansen to study the cause of 
leprosy and he proved the infectious etiology by demonstrating the rod 
shaped bodies from the nodules of leprosy. Thus Armauer Hansen (1841-
1912) discovered leprosy bacillus. The year 1873 is considered as the 
year of discovery of leprosy bacillus.2 
           Sheppard in 1960 transmitted M. leprae in to animals. Ehrlich in 
1882 described acid fast property of lepra bacilli. 
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Jeanselme of France in 1897 identified that nose was the site of 
entry of infection. Member of German commission named Georg Sticker 
visited ‘Homeless Leper Asylum’ in Mumbai to investigate leprosy and 
found bacillary clusters and intracellular globi in nasal smears.   
 Fromm and Wittman synthesized Dapsone for treatment in the 
year 1908. Paul Unna demonstrated cell-free sub epidermal zone or 
Grenz zone in histopathology of nodular leprosy in 1909. 
  
Epidemiological determinants 
Mycobacterium leprae is the causative agent for a chronic 
granulomatous disease called leprosy. This disease is classified into 
paucibacillary(PB) and multibacillary (MB) based on the number of skin 
lesions and nerve involvement.3 
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Prevalence:  
     It is defined as            
      The total no of leprosy cases under treatment as on March 31st  
      ------------------------------------------------------------------------ X 10000                        
                                Population as on March 31st 
 
Not a good indicator for assessing the programme. It indicates only 
the magnitude of the disease. It is useful for assessing multi drug   
therapy requirement and also reflects efficiency in patient management. 
 
Annual New Case Detection Rate:  
    
    It is defined as  
 
  No. of New cases detected  
          during a specified period of time 
          ----------------------------------------------- X 100000 
                       Population in that area  
                      during a specified period 
  
 This indicator is useful for monitoring the programme. 
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Proportion of child cases  
          Is defined as an 
 
 
 
 
High proportion indicates higher transmission of the disease. 
 
Proportion of female cases: 
 It is defined as  
 
 
 
 
It gives an indication whether the women have adequate access to   
diagnostic services.                                                                
 
                                               Number of female cases detected in a year 
                                       -----------------------------------------------------------    X   100 
                                                    Total new cases detected in a year  
 
                                       Number of child cases (< 15 years) 
                                                       detected in a year 
                                       ----------------------------------------    X   100 
                                       Total new cases detected in a year 
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Deformity rate: 
Percentage of patients with deformities among newly detected 
cases in a period of one year. This indicates delay in diagnosing 
It gives an indication whether the women have adequate  access to 
diagnostic services.    
  . 
Host Factors 
Seen commonly among the age groups of 20-30 years. Childhood  
leprosy indicates active transmission of disease. Both sexes are affected 
however there is a little male predominance.12 
 
Increased cases are seen in urban areas due to migration of rural 
population. Poor hygiene and living conditions of 8 to 10 people sharing 
a common room are important risk factors.  
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 Environmental Factors 
Bacilli survive for about nine days outside the body (dried nasal 
secretions) and 46 days in moist soil at room temperature. 
 
Social Factors 
Lack of education, ventilation and personal hygiene are risk factors 
for easy transmission of disease.  
                                                
Transmission 
The natural reservoir is Man and untreated cases of leprosy are the 
source of infection. However some animals like armadillos, chimpanzees, 
Mangabey monkeys may be infected with M.leprae but transmission from 
animal to human is very minimal. 
 
 
 
 
10 
 
   Nose is the major route of entry and exit of bacilli from an 
infected person. Modes of  transmission of infection are 
                    1. Droplet infection 
               2.  Contact – by skin to skin contact 
                               3.  In utero Transmission 
                     4. Transmission through    Ingestion (Breast Milk) –                          
Mothers with lepromatous leprosy.  
 
There is a long incubation period (average of 5 to 7 years) for 
leprosy. 4,50 
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MicrobiologicalAspects                        
M.leprae is a non-motile, acid-fast, obligate intracellular bacillus 
found within the macrophages, Schwann cells of nerves, muscle cells, 
endothelial cells of blood vessels, melanocytes of skin and chondrocytes 
of cartilages. 
Cell Wall: 
Contains inner electron dense and outer electron transparent layer. 
Inner layer has peptidoglycan, which is attached to arabinogalactan 
polymer modified by addition of mycolic acids. Unlike M.tuberculosis, 
M.leprae peptidoglycan had glycine instead of alanine found at the amino 
terminal. Outer transparent layer made up of lipopolysaccharides.. There 
are many antigens found on M.leprae, the most important being phenolic 
glycolpid-1 (PGL-1)3,5 Major lipid in the cell wall and also gives 
immunological specificity is PGL-1. 
Cell Membrane:   
It contains proteins and lipids. Major membrane protein-1 & 
protein-2, which is responsible for active and passive transport of 
substances across the cell. Phospholipid is the major lipid in the cell 
membrane.  
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Cytoplasm: 
28KDa, 17KDa and  Heat Shock Protein are the three major protein 
in the cytoplasm. 
 
Capsule: 
The two main unique lipids are (i) Pthiocerol  dimycocerosate (ii) 
Phenolic glycolipid 1 (PGL-1). Protects the bacilli from toxic effects of 
host  lysosomal enzymes, thereby causing immune evasion. 
 
Biological Properties 
Bacilli cannot be grown in artificial culture medium. It can be 
grown only in the animals like footpads of mouse and armadillo. The 
generation time is 11 to 13 days. Temperature required for the bacilli is 
less than 37O C. 6. 
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Pathology 
  Indeterminate Leprosy: 
One or a few vague hypo pigmented macules with or without 
sensory impairment. The histopathological features reveal only 
perivascular and periadnexal infiltrate of lymphocytes and histiocytes in 
the dermis with no epidermal change. 
The deep dermal nerves are often thickened and show intraneural 
infiltration by lymphocytes. The presence of acid-fast bacilli (AFB) 
inside a nerve, or an erector pili muscle confirms the diagnosis. 
75% of cases heal without treatment. Rest may progress to 
tuberculoid, lepromatous or borderline leprosy, depending on the host                   
immune status. 
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Tuberculoid leprosy (TT) 
Skin lesions are well-defined, 1–3 hypo pigmented hypoaesthetic  
having characteristic raised margin and a healing center. Skin biopsy 
shows tuberculoid granuloma characterized by dermal collections of 
epitheloid cells with Langhans giant cells surrounded by a rim of 
lymphocytes, which hugs the epidermis, and also seen around the  
perivascular and periadnexal structures. 
Dermal nerves shows lymphocytic infiltrate alone or epitheloid 
granuloma which erodes the nerve. Multiple swelling of the cutaneous 
and peripheral nerve trunks with caseous necrotic material seen called 
“segmental necrotizing granulomatous neuritis”. 
Borderline Tuberculoid Leprosy 
Multiple skin lesions with nerve involvement, which on 
Histopathological examination revealed large number of epitheloid 
granulomas with fewer giant cells and lymphocytes when compared to 
tuberculoid. Nerves are infiltrated with granuloma and later destruction of 
nerves occurs.  Occasional bacilli may be seen in nerves on careful 
examination.7 
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 Mid-Borderline (BB) Leprosy   
Histopathological examination  shows diffuse collections of 
epitheloid cells and some macrophages in the dermis which is separated 
from the overlying atrophic epidermis by a clear zone. Transverse section 
of a nerve shows “cut onion” appearance due to proliferation of 
perineural cells in an attempt to repair. 
 Borderline lepromatous leprosy. 
Histopathological examination shows atrophic epidermis with 
grenz zone which separates the epidermis from the infiltrate composed 
primarily of foamy macrophages unevenly mixed with lymphocytes. Acid 
fast bacilli  staining reveals numerous bacilli inside macrophages and 
Schwann cells.  
Lepromatous Leprosy  
Epidermis is always atrophic with underlying grenz zone. Dermal 
infiltrate composed entirely by foamy macrophages with minimal 
lymphocytes. There is perineural infiltration by macrophages. Acid fast 
bacilli staining revealed clumps of bacilli in Schwann cells, endothelial 
cells etc. 7,8 
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Case definitions of leprosy: 
Leprosy case is defined as an individual who has not completed the 
course of treatment and has one or more of the three cardinal features: 
1) Hypo pigmented or erythematous skin lesions with definite loss of 
sensation. 
2) Involvement of the peripheral nerves, by definite thickening with 
sensory impairment. 
3) AFB positive skin smear. 3 
 
Classification of leprosy 
 
  
The Madrid Classification 
 
Lepromatous type (L) 
                Macular 
                Diffuse 
                Infiltrated 
                Nodular 
                Neuritic, pure (possibly?) 
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 Tuberculoid type (T) 
                Macular (Tm) 
                Minor tuberculoid (micropapuloid) (Tt) 
                Major  tuberculoid (plaques, annular lesions, etc.) (TT) 
                Neuritic, pure (Tn) 
 
 Indeterminate group (I) 
                 Macular (Im) 
                 Neuritic, pure (In) 
 
Borderline (Dimorphous) group (B) 
                Infiltrated 
                (Others ?) 
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Indian Classification, 1955 
                                                            
Lepromatous Intermediate Non-lepromatous 
Maculoanesthetic Indeterminate  
Tuberculoid Borderline  
Polyneuritic   
                                         
 
The Ridley–Jopling classification 
 based on 
1) Clinical, 
2) histological, 
3) bacteriological and 
4) immunological 
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5-group system: 
1) Tuberculoid (TT), 
2) Borderline Tuberculoid 
3) Midborderline (BB),  
4) Borderline Lepromatous (BL) and 
5) Lepromatous (LL)  10,15 
 
CLINICAL FEATURES OF LEPROSY 
Indeterminate Leprosy  
This form of leprosy is commonly seen among school children. 
One to three ill-defined hypo pigmented macules size ranging from 1 to 5 
cm on the outer side of the extremities, buttock, face, and trunk with 
thickening of nerve. Slit skin smears may not reveal acid-fast bacilli. The 
lesions may heal spontaneously in a majority, small proportion may end 
in tuberculoid or lepromatous pole depending on the immune status of the 
person 11,13.  
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Tuberculoid Leprosy (T) 
Macules or plaques, 1 to 3 in number, and their size ranging from 
0.5 cm to 30 cm or more, anesthetic and are frequently associated with 
thickened nerve trunk. Commonest sites involved are the face, lateral or 
dorsal aspects of the extremities, and the buttocks. Enlargement of one or 
two nerves at the vicinity of the  skin lesions. They are unilateral and 
asymmetrical. Margins are sharply defined and infiltrated, but the centre 
is less infiltrated. The surface is dry and sweating is lost. Slit skin smears 
are negative. The lepromin test is strongly positive (2+ to 3+).  
 
 
Borderline Tuberculoid (BT)  
This is the commonest type of leprosy characterized by well 
defined infiltrated plaques,3 to 10 in number with well defined and raised 
margin in a part of a lesion, flat or  vague in another and presence of  
satellite lesions. Peripheral nerves are irregularly enlarged at the site of 
predilection in an asymmetrical pattern.  
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Midborderline (BB) Leprosy 
It is the most unstable and uncommon form of the disease. It is 
characterized by erythematous infiltrated plaques, 10 to 20 in number 
with a punched out or annular appearance, usually bilaterally but  
asymmetrically distributed. The plaque is depressed in the centre and has 
a sharp inner edge and sloping outer border. 
Nerve damage may be variable; It may be unilateral or bilateral 
depending on whether it evolved from the BT or the BL.16 
 
Borderline Lepromatous (BL) 
Macular, annular plaques or even nodular lesions may occur in BL. 
They are copper colored, and more infiltrated in the centre compared to 
the periphery. Number of lesions varies from 20 or more. Anesthesia is 
more in the centre than periphery. The lesions are bilateral and progresses   
towards symmetry. Diffuse infiltration of pinna and eyebrows are  seen. 
Lepromin test is negative. Glove and stocking anesthesia is not present 
thus  differentiating it from LL. 
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Lepromatous Leprosy: 
Highly infectious form of the disease where the cell mediated 
immunity is  lost, involves multiple organs like skin nerves, eyes, testes, 
adrenals,etc.Ill-defined macules which is either hypo pigmented or 
erythematous are present initially. The lesions are bilaterally symmetrical 
with smooth shiny surface.  Infiltration progresses gradually leading to 
the development of papules, nodules, and plaques, assuming a waxy 
appearance, on forehead, the chin, ear lobes , forearms and dorsum of 
hands. 
Madarosis is characteristic of lepromatous leprosy. Massive 
infiltration of bacilli in to the face leads to the development of leonine 
facies characterized by prominent ridges and furrows seen on the 
forehead ,thickened ears and loss of eyebrows. Nasal mucosa is involved 
in majority of cases, presenting  with nasal stuffiness and epistaxis. Nasal 
secretion is highly infectious. 
Corneal involvement leads to the development of ulceration, 
Lagophthalmos is due to the infiltration of leprosy bacilli in to the 
zygomatic fibers of facial nerves. Repeated orchitis in type 2 reaction 
causes testicular atrophy, and thereby gynaecomastia. Glomerulonephritis 
23 
 
occurs in type 2 reaction 17  and rarely may progress to end stage renal  
failure.  SSS  is –positive and lepromin test becomes negative .14 
 
 
 
 
RARE  VARIANTS OF LEPROSY:  
 
1) Lucio’s leprosy 
 
2) Lazarine leprosy 
 
3) Histoid leprosy  
 
4) Pure neuritic 
 
5) Localized  lepromatous leprosy 
 
 
 
Lucio’s leprosy: 
Is the rare form of the LL seen in Mexico. Diffuse infiltration 
involving the face and most of the body, giving waxy and shiny 
appearance to the skin, preceded by nasal congestion, epistaxis, 
hoarseness of voice, edema of hands. Madarosis may occur first. As the 
disease advances, thickening of eyelids gives sleepy or sad appearance.  It 
is called Lepra bonito, meaning beautiful leprosy.46 
 Lucio phenomenon (lepra manchada) is a type 3 lepra reaction 
occurs in Mexicans with diffuse non nodular form of leprosy, seen mainly 
in untreated patients. 18 
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Lazarine leprosy: 
           It is an unusual manifestation of BT Hansen’s manifesting as 
edema, formation of blister and ulceration of skin lesions which occurs 
spontaneously.  Predisposing factors are protein malnutrition. Pathology 
being accentuated hypersensitivity in type1 reaction.19,29. 
. 
Histoid  leprosy: 
A rare variant of lepromatous leprosy, characterized by the 
development of multiple cutaneous or subcutaneous nodules and plaques 
arising on an apparently normal skin with unique morphology of the 
bacilli and HP. 
Causes are 
 
1) Monotherapy with Dapsone 
 
2) Inadequate and irregular treatment 
 
3) Drug resistance to Dapsone   
 
4) Emergence of mutant organisms from a  Dapsone –  
 
susceptible population of  bacilli 21 
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Clinical features: 
 
Well demarcated nodules situated on the back, buttocks, face 
extremities and elbow. 
 
  
Difference between lepromatous and histoid nodule 
 
 
LEPROMATOUS NODULE HISTOID NODULE 
  
Edge, merges with the surrounding 
infiltrated skin.  
 
Well demarcated, arises on a 
normal looking skin. 
 
 
Histopathology: 
 
Numerous spindle shaped histiocytes, arranged in a whorled 
pattern, loaded with bacilli. Bacilli appear to be longer with tapering 
ends, arranged in parallel stacks called histoid habitus. Some lesions 
show nests of epitheloid cells called tuberculoid contaminants.22 
Differential diagnosis: 
1) Lepromatous nodule 
2) Molluscum  contagiosum 
3) Erythema nodosum 
4) Neurofibroma  
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Pure neuritic: 
Leprosy involving only nerves without skin lesions. Wade 
recognized this entity as pure neuritic form. The spectrum varies from 
tuberculoid to borderline lepromatous. If single nerve is  grossly enlarged 
and lepromin test becomes  positive then  the spectrum  is tuberculoid.. 
Ulnar and lateral popliteal nerves are commonly affected. However sural, 
superficial peroneal  and greater auricular nerves are also involved. Pure 
neuritic form is usually a borderline tuberculoid Hansen. Follow-up of 
these patients reveals the development of skin lesions in 35% of cases 
over 3–5 years with or without treatment. 
 
Localised Lepromatous leprosy: 
This is a rare form which contains either a single nodule or 
multiple nodules over a particular localised area sparing the remaining 
parts of the body. SSS revealed higher bacterial index, while rest of the 
skin is negative for bacilli. 
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Reactions of leprosy: 
 
     Definition: 
Reactions are due to acute episodes of hypersensitivity 
phenomenon to the antigen of M.Leprae. It occurs due to immunological 
instability of the host  
Types 
 
1. Type 1 lepra reaction, (synonyms - Coombs and Gell’s  type IV 
reaction )  called delayed hypersensitivity reaction  and is 
mediated by  T lymphocytes; 
2. Type 2 lepra reaction,  (synonyms- erythema nodosum 
leprosum (ENL), coombs and Gell’s type III hypersensitivity )  
mediated by humoral immunity, associated with immune 
complexes. 
3. Lucio phenomenon or necrotic lepra reaction. Leprae bacilli 
invade the endothelium of blood vessels and causes necrosis of 
arterioles. 
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Type 1 reaction: 
                   
  Seen commonly in the age group of 20-40yrs.Affects both the 
sexes equally. But male had slight preponderance of nerve damage with 
borderline tuberculoid. Occurs within 6 months of starting MDT in nearly 
80% of cases. Seen mainly in borderline spectrum (BT, BB, BL) of 
patients because of their immunological instability.23,48 
It can be either upgrading ( reversal reactions) or  a downgrading 
reaction  
Precipitating factors for upgrading reactions: 24 
 
1) Dapsone therapy  
2) pregnancy 
3) vaccinations 
4) post partum  
Precipitating factors  for down grading reactions 25 
 
 
1) infection 
 
2) stress 
 
3) surgery 
 
4) pregnancy 
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Grading of type 1 reaction: 24 
 
Mild  -Erythema, tenderness and swelling of a existing lesions. 
 
Moderate-Erythematous plaques with effusion of joints and edema 
of limbs. 
          Severe – ulceration of the skin lesion , painful neuritis with 
paralysis.  
 
Risk factors: 
 
1) Enlargement of a  nerve. 
 
2) Large patch over the face 
 
3) High bacteriological index 
 
4) Neuritis 
 
5) Disseminated patches involving larger areas  
 
 
 
Clinical features: 
Increased erythema and edema of pre-existing skin lesions with 
distinct edge. They are tender and warm. New lesions may occur but very 
rare. Sometimes ulceration occurs. Edema of hands and feet occurs. 
Acute painful neuritis is a serious complication result in sudden paralysis, 
e.g. foot drop, facial palsy. Rarely nerve abscess may occur. 
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Complications: 
     
1) Claw hand, food drop, wrist drop and facial paralysis. 
2) Ulceration  of  the  existing  lesions. 
 
Differential diagnosis: 
 
1) Urticaria 
2) Erysipelas 
3) Relapse 
 Reversal reaction  Down grading reactions 
Treatment  On taking treatment  Irregular treatment/defaulter  
Existing skin lesion  Well defined, more prominent 
Less prominent, margins 
undefined 
New skin lesions. No More new lesions  
Neuritis  No  new nerve damage New nerve damage occurs 
 BI Decreases Increases 
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Treatment: 
 
Standard Dose schedule for field purpose (WHO 1998) 
 
DOSE WEEKS OF TREATMENT. 
40mg daily 2weeks 
30mg daily 2weeks 
20mg daily 2 weeks  
15 mg daily 2 weeks  
10mg daily 2 weeks  
5mg daily 2 weeks 
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 Treatment of Type 1 lepra reactions (23) 
1) Mild reaction  
Chloroquine and aspirin 
2) Severe reaction 
Steroids and aspirin with or without large doses of 
clofazimine. splinting of affected nerves in the acute stage. 
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Type 2 reaction: 
  Also known as Roseolar leprosy, Erythema nodosum 
leprosum(ENL),  Lepromatous lepra reaction, acute exanthem of leprosy. 
Occurs most commonly in lepromatous leprosy and rarely in borderline 
lepromatous. Seen  among  20-40 years of age. Occurs  after 2 to 3 years 
of starting multi drug therapy.  
 
PRECIPITATING FACTORS: 26 
1) Psychological stress 
2) Intercurrent  infection 
3) Injury, surgery 
4) Drugs-dapsone,  rifampicin 
5) Ingestion of alcohol, vaccination 
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Classification of type 2 reaction: 28 
  Based on the mode of onset 
1)Rheumatic type-starts with fever, joint pain and later skin lesions 
develop. 
2)Exanthematous type-fever and skin lesions develop 
simultaneously. 
3)Mixed type-starts with fever, joint pain and skin lesions 
simultaneously. 
 
Clinical features: 
  Most characteristic skin lesion of type 2 is ENL. They occur as 
painful, evanescent (lasting for 2-3 days),erythematous raised, dome 
shaped nodules occurs in  crops in the evening (endogenous cortisol is 
least). Occurs on the face, arms, in a bilaterally symmetrical fashion. 
Recurrences occur at the same site. Papules, nodules and plaques are the 
classical lesions. 
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Clinical variants of ENL: 
1) Vesicular 
2) Bullous 
3) Haemorrhagic 
4) Pustular 
5) Ulcerated 
6) Erythema multiforme like 27 
 
 
SYSTEMIC MANIFESTATIONS 
 
EYE: 
Conjunctivitis, keratitis, iritis, episcleritis, and iridocyclitis and 
lagophthalmos occurs in type 2 reaction . 
 
ENT: 
Involves the mucous membranes of mouth, nose, resulting in 
rhinitis, epistaxis, ulceration and  perforation of nasal septum. 
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MUSCULOSKELETAL: 
  Arthritis and myositis are the commonest manifestation. Arthritis 
affects knee, metacarpophalangeal, interphalangeal joints, ankle and 
wrist. Dactylitis occurs as painful spindle shaped swellings of the 
phalanges. 
  
Lymphadenitis: 
Preauricular   lymphadenitis  is a premonitory sign in type 2 
reaction.  
EPIDERMOORCHITS: 
  U/L or B/L, acute painful swollen testis that later leads to atrophy. 
 
Grading of Type 2  lepra reactions: 28 
1) Mild: Temperature above 100˚F, few skin lesions on one or 
more extremities. 
2) Moderate: Temperature up to 102˚F, numerous skin lesions in 
all four limbs and few on the trunk and face with vesicle and 
pustule.Extracutaneous signs present. 
37 
 
3) Severe: Temperature  above 102˚F, vesiculation and postulation 
occurs in skin. Visceral involvement occurs. 
 
Complication 
1) Ulceration of skin lesion  
2) Blindness 
3) Infertility 
4) Perforation of nasal septum. 
5) Paralysis of involved nerves.  
 
 
Treatment: 47 
1) Mild/moderate reaction  
Rest + aspirin + chloroquine (when associated with 
bone/joint problems only) 
2)  Severe ENL: 
Rest + analgesics + steroids/thalidomide(23) 
                      Clofazimine in larger doses 
3) Thalidomide especially in cases of chronic recurrent ENL and 
steroid dependence.  
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Type 3 lepra reaction( Lucio phenomenon) 
 
Occurs in a non nodular form of  lepromatous leprosy. Presented as 
a diffuse shiny infiltrative lesions in Mexicans called Lucio Leprosy. 
Seen especially in untreated patients. Painful, ill defined red-bluish 
plaque surrounded by an erythematous halo present on the extremities. 
Later the lesions become purpuric, centre of the lesion undergoes necrosis 
and forms a black crust. Rarely bullous lesions which burst open to form 
a deep ulcer with jagged edges are seen. Patients remain a febrile 
throughout the course of reaction. 18 
 
 Complication: 
1) Secondary bacterial infection and  
     2) Secondary amyloidosis.  
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DIFFERENTIAL DIAGNOSIS OF LEPROSY 
1)  Macular Skin Lesion : 
  Vitiligo  
 Hypo pigmented or depigmented macules with normal sensation, 
no peripheral nerve thickening. Depigmentation usually  does not occur 
in leprosy. 
 Pityriasis versicolor-  
Hypopigmented macules usually smaller than leprosy macule, 
associated with fine branny scales. Sensation is intact, there is  no hair 
loss and and no  peripheral nerve thickening. 
  Pityriasis Alba 
Asymptomatic, round-to-oval, ill-to-well defined hypo pigmented 
macules on the face with fine scales. Seen in  children, mimicking 
inderminate leprosy. No impairment of sensation, loss of sweat and hair. 
Self resolution occurs. 
    Nevusachromicus 
Usually presents at birth, circumscribed hypopigmented macule 
with serrated margins. Does not disappear on diascopy. 
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 Nevus anemicus 
A vascular anomaly  which produces hypopigmented macule and  
it disappears on diascopy. 
  
  Post inflammatory hypopigmented macule 
There is a history of primary dermatosis. 
   Lichen sclerosus et atrophicus  
 There is hypo pigmented mildly atrophic plaque. Sensation is 
intact. Peripheral nerves are normal. Histopathology is diagnostic. 
Differential Diagnosis of Infiltrated Skin Lesions 
 Lupus Vulgaris- 
Lupus in early stage mimics tuberculoid leprosy. Infiltrated, 
well defined plaque, with a tendency to heal with scarring. They 
heal at one edge and spread at another, which is characteristic of 
lupus vulgaris  whereas central healing is  observed in leprosy.  
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    Psoriasis  
An erythematous infiltrated scaly plaque which mimics tuberculoid 
or borderline leprosy in reaction. Auspitz sign is positive.  Lesions 
situated on the extensor aspects of the extremities, scalp, and trunk 
associated with nail pits. 
 Sarcoidosis 
 Infiltrated plaque of sarcoidosis resembles tuberculoid or 
borderline leprosy. The sensations of the plaque and peripheral nerves 
remain normal. Histopathology is diagnostic.  
  Dermatophyte Infections (Ringworm or tinea corporis): 
  It mimics tuberculoid  or borderline leprosy. The inflamed borders 
are studded with papulovesicles. There is central clearing and peripheral 
extension of scales.  
   Granuloma Annulare 
Children and young adults are most commonly affected and it is a 
differential diagnosis for tuberculoid or borderline leprosy.  Symptomatic 
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papules and nodules in an annular configuration. Histopathology  reveals 
a necrobiotic pallisading granuloma which is characteristic of GA. 
 
  Syphilis 
  Annular  lesions  of  secondary  syphilis  resemble  leprosy but 
the involvement of the palms and soles, with generalized                      
lymphadenopathy, positive serology (TPHA or VDRL) differentiates it 
from leprosy.29 
Differential  Diagnosis for enlarged nerves are 
1) Leprosy 
2) Neurofibromatosis 
3) Charcot–Marie–Tooth disease (types 1 and 3) 
4) Refsum’s disease  
6) Amyloidosis 
5) Sarcoidosis 
 
Nerves apparently enlarged conditions are 
1) Cyst 
2) Tuberculous abscess 
3) Post-traumatic 
43 
 
 
 
 
 
                        DIAGNOSIS OF LEPROSY. 
   
SLIT SKIN SMEAR: 9 
 
Skin is cleaned with ether and a portion is gripped between thumb 
and index finger and blanch it .With a small – bladed scalpel an incision 
is made between the fingers about 5 mm long and 3 mm deep, with the 
pressure of the fingers being maintained .The blade is then turned at right 
angles to the cut and the wound is scraped several times in the same 
direction so that issue fluid and pulp collects on one side of the blade, and 
smeared on a glass slide. Two or more smears can be made on one slide. 
The sites should be noted, so that the same sites can be used for 
successive sets of smears during the course the treatment. 
Slides with smears on them should not be exposed to sunlight, 
dust; extremes of temperature and humidity. This may interfere with the 
capacity of the bacilli, to take up carbol fuchsin 
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Nerve biopsy: 
  Is essential for pure neural leprosy. A thickened sensory nerve is 
suitable, such as supra-orbital branch of the 5th cranial nerve, supra 
clavicular nerve, great auricular nerve in the neck, sural nerve at the back 
of the leg. These nerves do not contain motor fibers, therefore no risk of 
motor damage. 
HISTAMINE TEST: 
When histamine is injected intra dermally in to normal skin causes 
capillary dilatation, seen as a bright red flare known as histamine flare. 
This is due to axon reflex within the dermal nerves. 
SWEATING(NINHYDRIN  
For testing the integrity of dermal nerves. Anhidrosis is 
characteristic of skin lesions in tuberculoid leprosy. Injecting 0.2ml of a 1 
in 1000 solution of pilocarpine nitrate in to the tested lesion, paint the 
injection site with tincture of iodine, and then dust with starch powder. 
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Sweating causes blue discoloration of the powder. Absence of blue 
discoloration indicates that sweating is absent due to dermal nerve 
damage. 30 
 
 
Bacteriological index  
 
Density of bacilli in smears is known as bacteriological index.  It 
includes both solid staining and fragmented bacilli.  
: 
0:   No bacilli in 100 oil immersion fields 
1+: 1–10 bacilli in 100 oil immersion fields 
 
2+: 1–10 bacilli in 10 oil immersion fields 
 
3+: 1–10 bacilli in an average oil immersion field 
 
4+: 10–100 bacilli in an average oil immersion field 
 
5+: 100-1000 bacilli in an average oil immersion field 
 
6+: >1000 bacilli in an average oil immersion field. 
 
 
 
The Morphological Index (MI)  
  Calculated as the percentage of solid staining bacilli in a smear 
after examining 200 bacilli . Solid staining bacilli indicates only the 
living bacilli.31 
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WHO disability grading, 1998 
Hands and feet 9 
Grade 0: No anesthesia, no visible deformity or damage 
Grade 1: Anesthesia present, but no visible deformity or damage 
Grade 2: Visible  deformity or damage present. 
Each hands or foot assessed and graded separately. Damage includes 
ulceration, shortening, disorganization, stiffness and loss of part or all of 
the hand or foot. 
 
Eyes 
Grade 0: No eye problem due to leprosy, no evidence of visual loss 
Grade 1: Eye problems due to leprosy present, but vision not severely 
affected as a result of these (vision: 6/60 or better; can count fingers at 
6m) 
Grade 2: Severe visual impairment (vision: worse than 6/60;inability to 
count fingers at 6 m) 
Eye problems due to leprosy include lagophthalmos, iridocyclitis, 
and corneal opacities. 
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OCULAR LEPROSY: 
 
   Eyes will be affected in leprosy in 4 ways: 
1) Abnormal exposure of the eyes secondary to involvement of 5th 
& 7th cranial nerves 
2) Infiltration of the eyes secondary to direct invasion of lepra 
bacilli. 
3) Inflammation of the eyes secondary to infiltration. 
4) Complication of eyes secondary to involvement of surrounding 
tissues, eyelids, lacrimal glands.34 
In tuberculoid patients, eye is affected when there is an 
inflammatory patch over the branches of the facial nerve which innervate 
the Orbicularis oculi muscle responsible for closing the eyes, usually 
unilateral. 
Lepromatous Leprosy patient are susceptible for all complications 
 of eye, but  slower and symmetrical. 
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Madarosis: 
Loss of eyebrows and eyelashes is called madarosis due to direct 
invasion of M.leprae which destroys the roots of the cilia. 
Facial nerve abnormalities: 
Zygomatic branch of facial nerve which innervates the orbicularis 
occuli muscle is very much susceptible to leprosy bacilli results in 
lagophthalmos. As a result of loss of blinking, poor spread of tear and 
increased evaporation of tears leads to corneal ulceration. Secondary 
infection leads to endophthalmitis, resulting in blindness. Primary aim of 
treatment is to keep the cornea moist by giving tear substitutes. 
Physiotherapy is given by teaching the patient to close his eyes forcefully 
many times a day, thereby strengthening the remaining functioning 
muscle fibers. Lateral tarsorraphy is the surgical procedure for 
lagophthalmos. Systemic treatment is indicated. 
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INVASION OF THE EYE: 
Mainly by blood spread. The pathological lesions are in the 
conjunctiva, cornea, sclera, iris and ciliary  body. 
Leprous keratitis: 
Bacilli migrate along the myelinated corneal nerves to form 
microscopic lepromata or beads in to the corneal stroma .Lesions found 
on  superolateral aspect of cornea beneath the upper eyelid. Inflammation 
leads to vascularisation of corneal stroma and opacification resembling 
trachoma pannus. Difference being more deeper and superolateral in 
leprosy whereas  superficial and centre in trachoma. 
 Infiltration of the iris and ciliary bod  
Occurs via blood spread. Appearance of small lepromata near the 
pupillary margin .They  appear as round, white and shiny called iris 
pearls. Presence of M.leprae in iris and ciliary body cause  iridocyclitis, 
which is the most common cause of irreversible  blindness in leprosy.(35) 
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Deformity:  
Is defined as a visible impairment and the consequences of the 
impairment. 
Impairment : 
Defined as the physiological, anatomic or physiological losses 
resulting from a disease. 
                     1) Primary impairment 
                     2) Secondary impairments. 40 
 
 
Types of Deformities 
1. Specific deformities: due to infiltration with M. leprae.  
2. Paralytic deformities: due to motor nerve damage. 
3.Anesthetic deformities: secondary to impairment because of  
damage to motor nerves. 
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 Specific and paralytic deformities are examples of primary 
impairment. Anesthetic deformities are examples of secondary 
impairments.36 
 
Specific deformities: 
Occurs in lepromatous patient .face is commonly involved. 
1) Loss of eyebrows, 
2) Premature senility of the face  
3) Nasal deformities  
4) Deformities of external ear. 
5) Terminal phalange resorption  
6) Banana fingers. 
 
Specific deformity occurring in ENL: 
Hand is commonly affected with 
1) Intrinsic plus finger deformity (swan-neck deformity) 
2) Twisted fingers  
3) Non paralytic clawing. 
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Paralytic deformities: 
Commonly hands, less frequently in feet. Face occurs    in 
borderline and pure neuritic types of leprosy. 
1) Claw-finger, 
2) Claw thumb deformities. 
3) Wrist drop 
4) Lagophthalmos 
5) Facial palsy. 
 
Anaesthetic deformities: 
Feet is the commonly affected part  with 
1) Plantar ulceration  
2) Shortening of digits. 
3) Scarring of the sole 
4) Mutilation 
5) Tarsal disorganization. 
6) Corneal ulceration.   
7) Blindness. 37 
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Disability prevention: 
 
   Have three aims 
1)Prevent nerve damage and consequent nerve function deficit, 
deformities, disabilities, and disablement of the patients. 
 
2)Avoid secondary impairments (like wounds, ulcers, skin cracks, 
scar contractures, joint stiffness and serious eye problems). 
 
3).Recognize secondary impairments as early as possible, when 
they have occurred, manage them properly so that they do not become 
complicated and need expert advice and intervention, which is not easily 
available.38 
 
Disability prevention practices by affected persons have four 
 
Components:  
1) Skin care, 
2) Wound care,  
3) Joint care, and 
4) Eye care: 
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1) Skin care practice 
 
It is essential to  prevent a breach of the insensitive skin of the 
hands and feet. To achieve this, patients were taught to use the anesthetic 
hand carefully, avoiding injuries, uses protective footwear to avoid injury 
to the insensitive feet. 
 
   Hydration of the dry anesthetic skin of hands and feet and to 
prevent skin cracks. Health education to inspect his hands and feet at least 
once a day to identify any injury and takes treatment to get it healed at the 
earliest.  
 
 . 
2) Wound care:  
 
For gaping wounds patient needs medical advice without delay as 
they require immediate suturing, 
Small non gaping wounds will be washed with soap and water, it 
should be covered clean and dry. If it is not healed within 72 hours then 
seek medical advice. 
Persistent swelling with local warmth should alert the person of a 
possible closed injury, and medical advice must be sought without any 
delay. Till then, the part must be covered with a bulky compression 
bandage, rested, and kept elevated. 
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4)Joint care: 
 
Aim is to keep the joints in paralytic deformities mobile and free 
from contractures. Massaging the digits using a vegetable oil makes the 
skin soft. Repeated passive stretching of the bent digits helps in 
straightening. Active exercises to extend the finger joints.Oil massaging 
and stretching exercises are done daily for 10-15 minutes. 
If finger contractures have already occurred, should be opened out 
gradually without damaging the contracted structures using serial 
splinting.  
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 Plantar Ulceration (trophic ulcer) 
Commonest problem seen in leprosy found in about 10% of  
patients. They are seen mostly (80% of cases) in ball of the foot (medial 
part) in the metatarsophalangeal (MTP). 5% to 10% in the mid-lateral 
part of the sole underlying cubo-metatarsal joint and another, 5% to 10% 
in the heel.  
 
Etiology and Pathogenesis 
Three different reasons  
1. loss of sensation- 
The insensitive sole is injured due to nails, thorns, etc  the 
wound is neglected  because of loss of sensation , and it gets 
infected and develops into a ulcer. 
 
2. Through a fissure in the skin: 
The dry, anesthetic skin develops fissures or fine cracks .in 
corns and callosities and later ulcer. 
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3.Motor palsy:(accounts 90% cause) 
Forefoot is subjected to stress and strain during walking, and these 
are contracted by muscles of the foot. When these muscles are paralyzed, 
some areas are overloaded, causes the tissues to break down, leading to 
ulceration. 
 
 Stages in the pathogenesis of ulcer:  
1) Stage of ‘threatened ulceration’ in which the stressed 
subcutaneous tissues present in the ball of the foot undergoes traumatic 
inflammation. This may be identified by dorsal puffiness and splaying of 
the great toe and 2nd toe. The foot should be rested in a splint and kept 
elevated for 72 hours. No weight-bearing on the affected foot. 
 
2) Stage of ‘concealed ulceration’ (necrosis blister) :Continued 
walking causes necrosis and liquefaction of the  subcutaneous tissue, and 
the liquefied material reaches the surface and presents as a blister. The 
blister is padded well or, if there is a danger of breaking open, it is 
snipped and covered with Vaseline gauze, and a below-the-knee plaster 
cast applied. 
 
3) The third stage of ‘open ulceration’ where the necrosis blister 
breaks open and exposed to the external world.  
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Types of  ulcers 
1) acute, 
2) chronic,  
3) complicated and  
4) recurrent  
 
1) Acute ulcers:   
They are  frankly infected, purulent, covered with 
slough and are acutely inflamed.  
 
             2) Chronic ulcer 
                  Indolent ulcers with heaped up hyperkeratosis edges, 
having a serosanguineous discharge and covered with pale granulation 
tissue is called chronic ulcer. Simple chronic ulcer do not present any 
complication. Complicated chronic ulcers presents with involvement of 
deeper structures like an underlying bone, joint, and tendon sheath and  
pseudoepitheliomatous hyperplasia, malignant transformation (usually 
squamous cell carcinoma) and life-threatening infections like gas 
gangrene, septicemia or tetanus. 
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Management:  
          Acute ulcer needs  1) Absolute bed rest. 
                                        2)  Elevate foot 
                                        3)  Eusol bath, irrigation, dressing 
                                        4)  Limit surgery to drainage procedures 
                                        5) Antibiotics if needed 
 
 
           Chronic ulcer  
                 Simple ulcer can be managed by 
                               Scraping floor of ulcer, 
                              Vaseline gauze dressing 
                              Below knee POP cast or bulky dressing 
                              Protective footwear + foot-care training 
 
       Complicated Ulcer can be managed by 
                               Debridement 
                                Physiological rest by below knee POP. 
                                Protective footwear on POP removal                    
                                Skin graft large ulcers  
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    Recurrent ulcers  can be managed by 
  Scar revision using excision and suture, local flaps, distant flaps, 
free flaps,  footwear modification or corrective surgery and eradication of 
infection.  
 
Feet with plantar sensory loss and no muscle paralysis: 
Footwear have a tough outer sole, resist penetration by thorns, 
nails, glass pieces, etc, should not damage the foot, so no nails, 
uppers/straps and buckles .Automobile tire pieces are used as outer soles . 
 
Insensitive feet having intrinsic muscle paralysis: 
These feet requires a resilient, non collapsing and shock-absorbing 
insole insert that will reduce the stresses generated during walking 
.Microcellular rubber (MCR) of 10° to 20 used. 
 
Dense plantar scars due to previous ulceration: 
Modification of the footwear by adding a metatarsal bar obliquely 
across the sole about 25 mm proximal to the metatarsal heads or inserting 
a medial arch 41 
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In some feet the pressure will still be rather high at vulnerable sites.          
Maximum reduction of pressure is achieved by molding the insole 
thereby spreading the load of body weight over the entire plantar surface . 
 
 
Foot Care Practice: 
Foot is soaked in a water for 15 to 20 minutes and then the sole is 
rubbed against a coarse surface or pumice stone. which removes the 
heaped up layers of keratin, then neem oil is smeared over the sole and 
the dorsum without drying the foot.  Soaking softens the skin, rubbing 
removes the keratin layers, and the oil layer traps moisture and keeps the 
skin hydrated. 
 
Other precautions are  
1.  Protective MCR footwear even in a home.                    
2. Advice to  minimize walking (e.g. use bicycle where possible). 
3. To avoid walking long distances. 
4.  Find  safe  limits’ of walking. 
5. Have to walk a long distance, interrupt the same with periods of 
rest. 
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            National leprosy control programme: 42 
 
The government of India in 1943 appointed the Health Survey and 
Development committee with Sir Joseph Bhore as chairman. The 
committee was put forward  for the development of a  national 
programme of health services for the country. The committee’s 
recommendations on leprosy were creation of provincial leprosy 
organizations, increase the existing provision for institutional treatment of 
out-patients and in-patients and financial help to voluntary organizations 
engaged  in anti-leprosy work.   
 
Based on this recommendation, NLCP a central aided programme  
was started in 1955. Its aim was  to achieve control of leprosy through 
early detection of cases  and on dapsone domiciliary treatment through 
vertical units. It was done  by implementation of Survey Education and 
Treatment (SET) activities. 
 
  The goal of Government of India was  to eradicate leprosy by 
2000 and appointed a working group in 1980. Working group submitted 
its report in 1982 and recommended multi drug therapy. 
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The control programme was revised as National leprosy 
Eradication Programme( NLEP) in 1983.The districts were covered in a 
phased manner and all the districts in the country were covered by the 
year 1996. Main objective was to reduce case load to 1 or less than 
1/10,000 population.  
 
  In 1991, World Health Assembly resolved to eliminate leprosy at 
a global level by the year 2000. The first phase of the World Bank 
supported National Leprosy Elimination Project was  launched in 1993 
and completed in March 2000. 
                              
                      NLEP introduced the Modified Leprosy Elimination 
Campaign (MLEC) activities in the year 1997-98. Five such campaigns 
were conducted up to the year 2004. 
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The 2nd phase of the World Bank supported National Leprosy 
Elimination Project was launched in 2001 and completed in December 
2004. During this phase the responsibilities of NLEP were decentralized 
from the centre to the states. Leprosy services were also integrated with 
the General Health Care System from the vertical system. 
     
A system of monitoring of the programme was started in the form 
of Leprosy Elimination Monitoring (LEM) exercise jointly by Govt of 
India with WHO in 2002-2004. During the year 2003-2004, component 
of validation of case diagnosis was introduced. 
 
          Leprosy was declared eliminated as a public health problem in 
India at National level in the month of December 2005. From then 
onwards the program continues as an integrated part of general health 
service. 
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Components of the current programme: 
 1) Decentralized integrated leprosy services through general health 
care system . 
2) Capacity building of all general health services functionaries. 
3) Intensified information ,education and communication.     
4) Prevention of disability and medical rehabilitation. 
5) Intensified monitoring and supervision. (50)   
      
Major initiatives: 
1)  Main focus given to new case detection which is the main 
indicator for programme monitoring than prevalence.  
2) Treatment completion rate has been taken as an important 
indicator. 
3) Major emphasis on disability prevention and medical 
rehabilitation service to leprosy affected patients. 
 a) Dressing materials, supportive medicines and ulcer kits 
are provided to leprosy affected persons . 
b) Micro–cellular rubber foot is provided for protection of 
insensitive feet. 
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c) An amount of Rs.5000/ is provided as incentive to each 
leprosy patient who is  below poverty line, undergoing 
reconstructive surgery in the identified  institutions to 
compensate for  loss of wages 
  4) ASHAs have  been involved  in bringing out suspected leprosy cases 
from their villages for diagnosis and  treatment at PHC and follow up of  
confirmed cases  for their treatment completion. To motivate ASHA 
,incentive money given. 
 i) Confirmed case brought by them will be paid RS 100. 
               ii) On completion of full course of treatment of the case within 
                 specified time they were paid Rs 200 for PB cases and 400 for  
                multibacillary cases. 
 5)  Disability prevention and medical rehabilitation(DPMR). 
 
 6) Intensive IEC campaign with a theme ‘Towards Leprosy free India’ 
has been carried out towards further reduction of leprosy burden in the 
community,early reporting of cases and their treatment completion. 
Awareness generation activities are carried out through mass media and 
local media. 
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 Disability prevention and medical rehabilitation(DPMR): 
1) Implementation of DPMR activities as per guidelines and 
reporting its outcome e.g. treatment of leprosy reaction, ulcers, 
physiotheraphy.etc. 
2) Integrating DPMR services: convergence of NLEP services 
in to National Rural Health Mission facilities. 
3) To develop a referral system to provide prevention of 
disability services to all leprosy disabled persons in an 
integrated set-up. 
 
 Activities carried out in different setups: 
      Sub centre: 
                      Self care advice and monitoring activities are carried on. 
Disability and reaction should be referred to PHC. 
  Primary health centre : 
    Reactions can be managed if possible or referred. Identification 
of patients need reconstructive surgeries, foot wear and advice of wound 
care. Complicated ulcers, eye problems, reactions not able to manage 
should be referred. 
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District hospitals: 
              Should manage complicated ulcers and lepra reactions. Patient 
need reconstructive surgeries should be referred to district nucleus. 
 
MULTIDRUG THERAPY: 
      Objectives are  
a) To interrupt transmission of the infection in the community as 
rapidly as possible with the bactericidal drugs. 
b) Early detection and treatment of cases to prevent deformities. 
c) To prevent drug resistance. 
Rationale for MDT: 
Newly diagnosed ,untreated lepromatous case may harbor 1010 -
1011 viable M.leprae. Chance of resistance to a single drug is only 1in 
106-107 bacilli. Then the chance of resistance to 2 drugs is 1012-
1014,which is less than the no of bacilli found  at the time of diagnosis. 
The chance of bacilli resistant to all three drugs would be then nil. 
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WHO  recommendations: 
     1) MB leprosy-a person having 6 or more skin lesions and /or more 
than one nerve involvement. Treatment given 12 months ,and should 
be completed within 18 months. 
1) Rifampicin   - 600mg once monthly given under supervision. 
2) Dapsone       - 100mg daily ,self administered. 
3) Clofazimine -300 mg once monthly supervised ,and 50 mg 
daily, self administered. 
     2) PB leprosy-person having 1-5 skin lesions and/or only one nerve 
involvement. Treatment is given for 6 months and should be  
completed within 9 months.        
1) Rifampicin   - 600mg once monthly given under supervision. 
2) Dapsone       - 100mg daily, self administered. 
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                                       Materials and methods 
Study population 
Entire population of Alanganallur block . Permission from ethical 
committee of the hospital obtained for the study. 
 
Methodology: 
The survey was  conducted with the help of 25 Accredited Social 
Health Activist (ASHA) appointed for that block by Director of Leprosy  
and their field work was  supervised by Health inspectors, Non medical 
supervisors and Investigator. These ASHA workers were trained to 
undertake house to house survey in their villages to identify suspected  
cases of leprosy, leprosy-related disability and complications and old 
cases using verbal questionnaire. I the Investigator, examined these 
suspects to filter out non leprosy cases and the leprosy cases were 
confirmed by a thorough clinical examination, slit skin smear and biopsy 
when necessary.    
  Soft ware used is SPSS Chi-square test. 
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Training to ASHA: 
Initially 2 days comprehensive training programme was conducted 
for these ASHA workers. During the training, audiovisuals and clinical 
case description which  includes  all aspects  of  leprosy, disability ,and 
clinical features  differentiating it  from non leprosy  cases was taught. 
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Inclusion criteria:  
 
                          All confirmed cases of leprosy among the  suspected  
cases in Alanganallur block were included in the study. The cases were 
categorized as new cases, old cases and defaulters. 
                       New case of leprosy is defined as a person with at least one 
cardinal feature of leprosy but who had not taken treatment for the 
leprosy so far, irrespective of duration of the  disease. The cardinal 
features of leprosy are hypo pigmented or reddish skin patches and with 
definite signs of anesthesia, nerve involvement and slit skin smear 
positive for acid fast bacilli. This includes previously undiagnosed cases 
of Hansen’s with symptoms of the disease of longer duration as well as 
cases of recent onset.  
                      Old case is defined as a person with signs and symptoms of 
leprosy, who had either taken treatment fully or in part . 
                      Defaulter is defined as a person who is not  taking treatment 
continuously for 3 months in paucibacillary group and six months in 
multibacillary group. 
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 Exclusion criteria: 
 
         Non leprosy cases in Alanganallur block and leprosy patients 
from outside Alanganallur block. 
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Observation and Results: 
 
                         Total population enumerated in  Alanganallur block was  
94544.Total  number of ASHA’s involved in this study were 25. 
Population surveyed door to door  by ASHA’s from 1.4.2013-31.3.2014 
was 77585(82%) . 
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   Table 1: DEMOGRAPHY          
Variables Alanganallur 
Total population enumerated  94544 
Total number of  PHC 4 
Total population surveyed 77585(82%) 
Total number of  suspects  894(1.15%) 
Number of suspects examined. 803(90%) 
 Among 77,585(82%) people screened, the number of suspected cases 
found were 894 (1.15%). Among this suspected  people  91 (10%)were  
lost for follow-up. Total number of suspected cases examined were 
803(90%). 
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 Table 2: Distribution of cases in the survey 
Variables Number Percentage 
 Examined suspects 803 
Leprosy cases 83 10% 
Non Leprosy Cases 720 90% 
  
       Among the suspects examined (803), the leprosy cases constituted 83 
(10%) and non leprosy cases were 720 (90%). 
.  
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       Table 3: Distribution of leprosy cases 
 
Variables Number 
Total Leprosy Cases  In Survey 83 
New Leprosy Cases 12 (15%) 
Old Case On Treatment 6 (7%) 
Released from treatment (RFT) Cases 60 (72%) 
Defaulters 5 (6%) 
 
 Among the 83 cases of leprosy in the survey, 12 (15%) were new leprosy 
cases. Old cases on treatment were 6 (7%). RFT includes 60 cases (72%) 
and defaulters were 5 (6%). 
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 Table 4:  Distribution of non leprosy cases 
S.No. Diagnosis Count Percentage 
1 Tinea versicolor 401    54% 
2 Tinea corporis 153    21% 
3 Pityriasis alba 40             5% 
4 Eczema 34             5% 
5 Vitiligo 28 4% 
6 Polymorphic light eruption 16 2% 
      7 Post Inflammatory hypopigmentation 11 1% 
8 Allergic contact dermatitis 10 1% 
9 Nevus Achromicus 8            1% 
10 Miscellaneous 37            5% 
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 Among Non Leprosy Cases Tinea Versicolor contributes 54% and 
Tinea Corporis 21%, Pityriasis Alba 5%, Vitiligo 4%, Polymorphic Light 
Eruption, 2% post inflammatory hypopigmentation, nevus achromicus 
contributes less than 1%.Miscellaneous cases include keloid, furuncle, 
neurofibroma and insect bite allergy.(table 4). 
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      Table 5:   Classification  of New leprosy cases. 
S.No. Variables Numbers Percentage 
1 Total new  leprosy cases 12  
2 Paucibacillary cases 7 58% 
3 Multibacillary cases 5 42% 
 
Among 12 newly diagnosed leprosy cases, PB contributes 7 (58%) and 
MB contributes 5 cases (42%). 
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             Table 6: Age wise distribution: 
 
Variables Number Percentage 
Child 2 17% 
Adult 10 83% 
 
 
Among 12 new cases, 2 (17%) cases were children (under 15 
 years)   and 10 (83%) cases were adults. 
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      Table 7: Age  wise distribution  
 Paucibacillary Multibacillary 
Age No. % No. % 
< 20 Years 2 29% 0 0% 
20-40 Years 3 43% 0 0% 
41-60 Years 2 29% 5 100% 
> 60 Years 0 0% 0 0% 
 
Among PB the commonest age group affected is 20-40 years which 
contributes 43%. Among MB the commonest age group affected is 41-60 
years. All the cases belong to this age group. 
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                  Table 8: Sex wise distribution 
   Paucibacillary Multibacillary 
Sex No.      (%)     No.      % 
Male 4       (57%)      3       (60%) 
Female           1       (14%)      2       (40%) 
Male Child           1       (14%)      0        (0%) 
Female Child           1       (14%)      0        (0%) 
TOTAL           7      5 
 
           Males accounted for 57% of PB type, ,females 14%and children 
28%. Male: female ratio among MB cases was 6:4.There were no 
childhood MB cases.  
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      Table 9: Spectrum of Disease among Male and Female 
Type of Leprosy Male % Female % 
TT 1 8% 1 8% 
BT 7 58% 2 17% 
BB 0 0% 0 0% 
BL 0 0% 1 8% 
LL 0 0% 0 0% 
 
                    BT Hansen is the most common in male and female which 
constitutes about 58% and 17% respectively. TT Hansen constitutes 8% 
among male and female. A single case of BL Hansen was seen in a 
female. No case of lepromatous leprosy was found.  
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Among 12 cases 6 had nerve involvement in which 4 were males and 2  
females. 
           Table10: Nerve Involvement in New Leprosy cases 
                  
Type of Leprosy Male % Female % 
Nerve Involvement among Male 
and Female 4 67% 2 33%
 
Nerve involvement is more common in male than in females. 
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Table 11: Nerve involvement in correlation with the spectrum of 
leprosy. 
Type of Leprosy Male % Female % 
 
 
Total % 
BT 4 67% 1 16.5% 
 
 
83.5% 
BL 0 0% 1 16.5% 
 
 
16.5% 
 
  Among BT Hansen 67% of male and 16.5% of female had nerve 
involvement. Among BL Hansen one female had nerve involvement.  
Among 6 patients, 4 had single nerve involvement and 2 had 
multiple nerve involvement. Among 6 cases with nerve involvement 
Ulnar nerve is more commonly involved than other nerves. . 
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Table 12: Duration and site of skin lesion 
S.NO PATCH SITE DURATION 
1 Hypopigmented Knee 2 months 
2 Hypopigmented Right forearm 1 months 
3 Hypopigmented Trunk 1-2 years 
4 Hypopigmented Face,Upper 
limb,Lower 
limb 
4 years 
5 Hypopigmented Elbow 6 month 
6 Hypopigmented Back,trunk 3-4 years 
7 Hypopigmented Right leg 3 months 
8 Hypopigmented Trunk 2-3 years 
9 Hypopigmented Left arm 2 months 
10 Erythematous Right thigh 1 year 
11 Hypopigmented Back 2 years 
12 Hypopigmented Right face 1 year 
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 Table (12) shows the duration of the lesion, in that nearly 7 cases  had   1 
year and above 1year  duration. 
Deformity 
                Among 12 cases, 2 (17%) had deformity. 
Reaction:          
                Among 12 case of leprosy, 1 male had type 1 reaction. This 
contributes 8% of newly diagnosed cases. 
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 National Leprosy Eradication Programme(NLEP)  evaluation  
indicators: 
 
Annual new case detection rate(ANCDR) 
 
   No. of New cases detected  
           during a specified period of time 
     =    ----------------------------------------------- X  100000 
Population in that area  
during a specified period. 
 
Our survey detected 12 new leprosy cases. So ANCDR is  
     12 
  ---------- X 100000 = 15.5 
  77,585 
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Prevalence: 
 
 
 
 
 
 
   10 
--------- X 10000 = 1.3 
 
77,585 
 
 
Proportion of multibacillary(MB) cases 
 
 
 
                                            Number of MB cases detected in a year 
Proportion of MB cases = ---------------------------------------------------- 
                                              T 
 
otal new cases detected in a year 
 
 
  
No. of balance cases under treatment as on 31st March 
----------------------------------------------------------------------------------------------- 
                     Population as on 31st March 
X 10000  
                                            Number of MB cases detected in a year 
                                      --------------------------------------------------- X 100 
                                              Total new cases detected in a year 
  5 
----- X 100 = 42 
 12 
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Proportion of child cases 
 
 
 
 
 
 
 
 
 
 
Proportion of female cases: 
 
 proportion  indicates  high transmission in the population. 
 
High  
 
 
 
 
 
                                                      Number of child cases (< 15 years) 
                                                                       detected in a year 
                                         ------------------------------------------------------------- X 100 
                                                         Total new cases detected in a year 
  2 
----- X 100  =  17 
 12 
  3 
----- X 100 = 25 
 12 
                                                      Number of female cases detected in a year 
                                               ----------------------------------------------------------- X 100 
                                                         Total new cases detected in a year 
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                                                      Number of deformity cases detected in a year 
Proportion of deformity cases = ----------------------------------------------------------- X 100 
                                                         Total new cases detected in a year 
  2 
----- X 100 = 17 
 12 
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Table 13:  Comparison of Survey Indicators with 
NLEP, DPMR- Alanganallur Block (2012-2013) 
Variables Survey Data  
NLEP.DPMR 
(1.04.2012-
31.03.2013) 
 
 
p value  
 
ANCDR/100000 15.5 11 
0.441 NS 
Prevalence rate/ 
10000 1.3 1 
1.000 NS 
Proportion of MB 
Cases 42 75 
0.020  SIG 
Proportion of PB 
Cases 58 25 
0.003  SIG 
Proportion of 
children 17 8.3 
0.137 NS 
Proportion of female 25 42 
0.097 NS 
 
             DPMR- District Progressive Monthly Report. There is a 
statistically significant p value seen for proportion of multibacillary(MB) 
cases and paucibacillary( PB) cases. NS indicates not significant. NLEP-
National Leprosy Eradication Programme . 
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Table-14 :   Comparison of Survey Indicators with NLEP 
DPMR Alanganallur Block(2013-2014) 
                                      
 
  DPMR- District Progressive Monthly Report. On comparison the p 
value is not statistically significant on comparing the survey data with the 
NLEP DPMR 2013-2014. 
Variables Survey Data . 
NLEP 
DPMR 
(1.04.2013-
31.03.2014)
 
p value 
ANCDR/100000 15 13.8 
1.000 NS 
Prevalence rate 1.3 0.92 
1.000NS 
Proportion of MB Cases 42 40 
0.956 NS 
Proportion of PB Cases 58 60 
0.976 NS 
Proportion of children 17 20 
0.784 NS 
Proportion of female 25 47 
0.036 NS 
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Table15:    Comparison of Survey Indicators with NLEP 
Tamil Nadu Government Data(2013-2014) 
 
 
There is statistically significant p value seen in ANCDR of survey data 
compared with NLEP Tamilnadu-2013-2014  
 Survey Data 
NLEP, 
TamilNadu 
(1.04.2013-
31.03.2014) 
p value 
ANCDR/100000 15 5.057 
0.044  Sig 
Prevalence rate 1.3 0.4 
1.000 NS 
Proportion of MB 
Cases 42 54 
0.377 NS 
Proportion of PB 
Cases 58 46 
0.404 NS 
Proportion of 
children 17 9 
0.205 NS 
Proportion of 
female 25 29 
0.742 NS 
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                                      DISCUSSION 
DEMOGRAPHY 
  Alanganallur is a Block Primary Health centre (PHC) in Madurai 
district which  includes 4 PHCS with the enumerated population of  
94544. Population surveyed door to door from 1.4.2013-31.3.2014 
includes 77585(82%). 
  The total number of persons examined in our study were 77585 
which was 82% of the enumerated population which is higher compared 
to a similar study undertaken by Shetty et al 51 where the number of 
people surveyed were 27998 which was 69% of the enumerated 
population. This shows more population was covered by  our  survey 
team. 
The number of suspects detected by ASHA’s in our study was 
894(11.5%) compared to 514(18%) of Shetty et al study.51.This is lower 
in our survey, the reason being low prevalence of leprosy in Alanganallur 
compared to their surveyed district which was Karjat district of 
Maharashtra. 
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  90% of the suspects were screened by our team whereas 28% 
were screened by Shetty et al.51 This shows 3 fold increase in the 
sensitivity of screening in our study. 
 
Incidence or Annual New case detection rate (ANCDR) 
  The overall ANCDR of leprosy cases observed in our study was 
15 per 1, 00,000 population. This is lower than the ANCDR, in the study 
conducted by Shetty et al.51 which was 140/1,00,000. Alanganallur is a 
high prevalent area in Madurai district of Tamil Nadu but its prevalence 
is low compared to their surveyed district Karjat in Maharastra. 
 
   Our study is compared with the Tamil Nadu State Govt National 
Leprosy Eradication Programme (NLEP) monthly progress report 2013-
2014 data 43 according to which the ANCDR is 5 per 1,00,000. This 
shows a threefold increase in ANCDR in our study. 
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Our study is also compared with NLEP District Progressive 
Monthly Report (DPMR) Alanganallur block April 2012-to-2013 44 
 where the ANCDR was 11.This shows only slight increase in ANCDR in 
our survey, which is not stastically significant. 
But  actually  in our  survey ,  nearly 60% of the  Cases (table 12) 
have 1 or  more than  1 year duration. So if active surveillance  had been 
carried out earlier, all these cases would have been detected  and treated  
earlier thus preventing the  deformity .The ANCDR would have  also 
been increased in the year (2012-2013). This highlights the importance 
of active surveillance in detecting leprosy cases earlier. 
  Our survey is also compared with the ANCDR of NLEP District 
Progressive Monthly Report (DPMR)  of the same block for the period 
from April 2013-to-March 2014, where it was 13.8 per 100000 
population which is nearly similar to our survey.45 
But actually this includes the cases detected in our survey along 
with  the voluntarily reported cases which was  only 4 in number. Hence 
our survey cases constitute 75% of ANCDR of Alaganallur Block. This 
again emphasis the importance of active surveillance in detecting 
leprosy cases. 
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 PREVALENCE 
The prevalence of leprosy cases observed as on 31st March 2014 in 
our study was 1.3 compared with the NLEP Tamil Nadu Govt data 43 
where it was 0.4. This revealed three times higher prevalence in our 
study. 
The prevalence in our study is also compared with the prevalence 
of NLEP, DPMR Alanganallur block data for past 2 years, that is 2012-
2013 and 2013-2014 which was 1 and 0.92 respectively which is slightly 
lower than our study. 44,45. 
Prevalence is not a good indicator for use in the programme 
because it indicates only the magnitude of the problem, i.e.  the total 
cases registered and undergoing treatment at a point of time. However it 
is useful for assessing multidrug therapy requirement and also reflects 
efficiency in patient management. 
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 Proportion of child cases: 
The proportion of child cases in our study was 17% compared to 
NLEP Tamil Nadu State 43 where it was 9%. This is also compared with 
DPMR Alanganallur block data  for past 2 years where it was 8 (2012-
2013) 44 and 20 (2013-2014).45 This shows increase in child proportion in 
our study. 
This warrants the health functionaries that there is higher 
transmission of leprosy in that block and need continuous monitoring and 
contact survey.  
The proportion of children among new cases in our study is 17% 
compared to 13% by Shetty et al.51 This is higher in our study. This again 
indicates more active transmission of infection in the block. 
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AGEWISE DISTRIBUTION: 
  In our study, more number of cases was seen in the 41-60 years 
age groups. This is comparable to the increasing ANCDR from the lowest 
of 0.96 to 20.72 at the age of 60 years and above as observed in the study 
conducted by Anil Kumar et al.52 
Among PB the commonest age group affected is 20-40 years which 
contributes 43%. Among MB the commonest age group affected is 41-60 
years and all the cases belong to this age group. 
 
SEX 
The proportion of female cases in our study was 25%  and is 
slightly lower in our study compared to the NLEP Tamil Nadu State 
data43S which was  29% and  is not statistically significant. 
  Our study is also compared with the DPMR Alanganallur.  
Block data 2013-2014 45 where they were 47%. This shows decrease in 
female proportion in our survey. 
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The proportion of female cases in the Shetty et al 51 study was 13%, 
which is low compared to our study. The higher proportion of female 
case detection in our study  reflects the  adequate access of females in 
Alanganallur by our survey team. 
 
PROPORTION OF MULTIBACILLARY CASES(MB): 
The proportion of MB cases in our study was 42 which was  lower 
than the NLEP Tamil Nadu state government data 43 where it was 54 
which is stastically significant. 
Our study is also compared with DPMR of Alanganallur block for 
the year 2012-2013 and 2013-2014, which was 75 and 40 
respectively.44,45.  
DPMR data for the year 2014 includes our survey cases too. This 
highlights the early diagnosis of paucibacillary cases in our survey 
and relative reduction in the proportion of multibacillary cases in 
2014.  
This  again emphasizes the need for active surveillance in 
detecting leprosy cases and thereby reducing the morbidity of the 
disease.  
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          MB cases contributes 5(42%) out of 12 cases, compared to  45% 
cases in the study by  Shetty et al 51  which was comparable  to our study. 
 
DEFORMITY  RATE: 
Proportion of deformity cases in NLEP Tamil Nadu data 43 is 8% 
where as in our survey it is 17%. This is higher than the state data. This 
may be due to the high endemicity and actual reporting in our survey. 
The number of people with deformity constitutes 17% in our study 
which is slightly lower than that in the study by Shetty et al (20%)  
In our survey 10% of suspected cases could not be traced for 
examination by the investigator. Thus there is a possibility of detection of 
one more case if all the left over 91 cases were screened. 
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                   Summary 
• Our survey detected 83 leprosy cases out of 77,584 population 
during the year 2013-2014. 
• 12 were new leprosy cases. 
•  6 cases were already on treatment  
• 60 cases were released from treatment, 5 cases were defaulters 
• 12 new cases  include 7 PB  and 5 MB cases. 
• Among PB 2 were children and 10 were adults.  
• It includes 2 TT, 9 BT and 1 BL Hansen’s. 
• 6 cases had nerve involvement. Ulnar nerve is commonly involved.  
• 2 cases had deformity and 1 case had Type-1 reaction.  
• The prevalence of the survey was 1.3.  
• The ANCDR of the survey was 15.5 per 1,00,000 population.     
•  Proportion of MB and PB cases were 42 and 58 respectively.  
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• Proportion of child cases was 17.  
• Proportion of female cases was 25.  
• Disability rate was 17. 
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                         CONCLUSION                                                        
 There is a large backlog in the detection of leprosy cases in the 
endemic areas. There are also problems faced by patients in accessing 
the state health care facilities. This warrants the need for active 
surveillance in the community to attain the actual elimination.   
However it may be difficult for the government to implement 
active surveillance as a part of National Leprosy Eradication  
Programme due to financial concern. At least active surveillance needs 
to be  reintroduced in a high endemic areas to reduce the case load and 
thereby attaining the actual elimination.   Alternate strategies must be 
considered to bring out the undetected cases in the community. 
Information, Education and Communication activities should be 
strengthened to increase the level of awareness in the community and 
motivate the people to reach the health system. 
It  is  necessary to ensure capacity building among primary health 
care staff and enforce the  accountability by strict supervision. 
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BT  Hansen with Type 1 reaction 
 
 
BL Hansen with loss of sweat over the patch and adjacent compensatory  
hyperhidrosis 
.  
  
 
 
 
B 
 
B  
 
b 
  BL Hansen’s with uicer  of  both palms  
 
 
 
Hypo pigmented patch  with  loss of hair. 
  
Biopsy  on  low  power shows epitheloid granuloma. 
 
 
 
 
 
 
  
 
 Dermis  shows epitheloid granuloma with giant cells . 
PROFORMA 
1. NAME:   2. AGE:  3. SEX:  4.ADDRESS: 
5. OCCUPATION:  6. INCOME:  7. SOCIOECONOMIC 
STATUS: 
 
8. CHIEF COMPLAINTS: 
Skin lesion: 
Systemic complaints: 
9. HOPI: 
Onset-sudden/insidious 
Progression-slow/rapid 
Skin lesion -  
       
Site – 
Sensation-loss of sensation/painful. 
Constitutional symptoms:fever/athralgia,malaise,fatigue, 
                                                    Headache. 
Neuritis –neural pain/tingling and numbness. 
Systemic involment: 
            Eye-redness/blurring of vision/pain /photophobia 
Edema of hands /feet 
Swollen and tender testis 
Muscle pain/bone pain 
Joint pain and swelling 
Rhinits /epistaxis. 
10. Past history: 
               DM/HT/other systemic disease. 
              Hansen in the past-yes/no 
             If yes - when  
                             Type of Hansen . 
          (from record /no of patch/no of nerve) 
11. Treatment H/O: 
             ALT taken in the past- 
            Regimen taken-Dapsone monotherapy/PB-MDT 
             MBMDT. 
    Date of Rx started on – 
    Date of completion- 
     Default /regular/ dropout- 
12. Family history: 
                 Hansen in family members  /type of Hansens /treatment taken. 
13. Personal H/O: 
         Married/single 
Children 
Smoker/Alcohol. 
14. General examination:         VITALS-P.R:  BP:   
           Febrile     SYSTEMS-CVS: 
          Anemic                 RS: 
         Pedal edema                     ABD: 
       Generalised lymphadenopathy.          CNS: 
15. DERMATOLOGICAL  EXAMINATION 
  No and Type of lesions     -     patch 
                                             -    papule 
                                             -   nodule 
                                                -   plaque 
                                                -   vesicle /bulla 
                                                -   ulcer/necrosis. 
 
 
Margin - well/ill defined  
              - Extent of margin  
Surface - warm  
               - Shiny /edematous 
                 - Scaly/exfoliation 
Colour - erythematous/hypopigmented  
Infiltration: 
Tenderness:  
Site : 
Distribution –symmetrical/asymmetrical/  U/L   /  B/L 
Sensation-hypoaesthetic/hyperaesthetic/anesthetic 
Other skin lesion - Madrosis 
   - Nasal depression 
   - Ear lobe infiltration  
   - Leonine facies  
   - Edema of hands/feet 
   - Gyanecomastia  
16. Nerve examination  
             Cranial nerve: 5th nerve  - corneal sensation  
-  Sensation on face. 
            7th nerve  - facial expression  
                                                           - wrinkling of forehead 
                                                           - blinking of eye /Lid lag/deviation of mouth. 
                                                       
                                               
 
17. Peripheral nerves              
  Thickening Consistency Tenderness Nodularity
Supra orbital 
nerve 
Right     
 Left     
Facial nerve R     
 L     
Greater auricular 
nerve  
R     
 L     
Supra clavicular 
nerve  
R     
 L     
Radial nerve  R     
 L     
Ulnar nerve  R     
 L     
Radial cutaneous 
nerve  
R     
 L     
Lateral popliteal 
nerve 
R     
 L     
Post  tibial nerve R     
 L     
Sural nerve R     
 L     
       
18. Sensory  system : 
       Anaesthesia along nerve course - partial / complete loss. 
                                                              
             Nerve trunk involvement-tem/pain/touch involvement. 
           Glove and stocking anaesthesia. 
19. Acute palsy  
Claw hand –partial/total 
Wrist  drop  
               Foot drop  
               Facial palsy  
20. VMT - ulnar nerve - little finger abduction            card test                         
Froments sign 
               Radial nerve –wrist extension  
          Median nerve –pen test 
         Lateral popliteal nerve-dorsiflexion of foot 
        Posterior tibial nerve-eversion of foot 
21. Other systems: 
         Eye –conjunctivitis,iridocyclitis  
         Arthrits-jt swelling /tenderness 
22. Investigations:SSS                         BIOPSY 
23. Diagnosis. 
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1 Sibiraj 11 M AGN HP KNEE 2m S 1   BT PB
2 Thangaponnu 14 F AGN HP R.FM 1m S 1 1 TT PB
3 Rajesh 22 M AGN HP TRUNK 1-2y S 1 1 TT PB
4 P.Lakshmi 50 F AGN HP F,UL,LL 4y M 1 LPN,UN B 1 1 BT MB
5 Amudha 40 F AGN HP ELBOW 6m S 1 U 1 1 BT PB
6 Papathy 50 F AGN HP BACK,TRUNK 3-4y M 1 1 LPN,UN B 1 1 BL MB
7 Sonimuthu 50 M AGN HP TRUNK,LEGS 3m M 1 1 UN U 1 1 BT MB
8 Sahadevan 49 M AGN HP R.LEG 2-3y S 1 LPN U 1 1 BT PB
9 Chandran 53 M AGN HP TRUNK 2m M 1 UN B BT MB
10 Thothan 50 M AGN HP R.ARM 1y S UN U 1 BT PB
11 Mookaiya 50 M AGN HP THIGH 2y M 1 1 BT MB
12 Chinnadurai 34 M AGN EP THIGH 1y S 1 1 1 BT/T1 PB
MASTER CHART
Cutaneous Nerve Thickening Sensory Motor Palsy Skin Biopsy
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1 S.Muthia 60 M AGN DEFAULTER
2 Muthumal 60 F AGN DEFAULTER
3 Kamaye 60 M AGN DEFAULTER
4 Alagappan 50 M AGN DEFAULTER
5 Palaniammal 52 F KN DEFAULTER
6 Pandiarajan 13 M AGN OLD CASE ON Rx
7 Chitradevi 30 F AGN HP R.ARM UN U OLD CASE ON Rx
8 R.Santhanapandi 29 M AK HP LEG OLD CASE ON Rx
9 Raja 17 M AK HP R.THIGH OLD CASE ON Rx
10 Cheti 34 M AGN HP FACE OLD CASE ON Rx
11 Maduraiveeran 30 M VMP HP TRUNK OLD CASE ON Rx
12 Periyakarupan 60 M AK HP FLANK RFT
13 Manikam 70 M AK HP KNEE LPN U RFT
14 Theivam 50 M AK RFT
15 N.Bosh 19 M AGN RFT
16 Chellamani 51 M AGN RFT
17 Bathrakali 50 F AGN RFT
18 Nagamal 70 F AGN RFT
19 RFT 23 M AGN RFT
20 Balamurughan 30 M AGN HP RFT
21 Veeran 60 M AGN RFT
22 Muthupandi 40 M AGN LPN B RFT
23 Palaniammal 55 F AGN RFT
24 K.Kannan 60 M AGN RFT
25 P.Karupusamy 47 M AGN 1 RFT
26 Alagu 8 M AK 1 RFT
27 Kilnatan 37 M AK RFT
28 K.Kumuran 43 M AK RFT
29 Odiyan 50 F AGN HP RFT
30 N.Manikandan 56 M AGN RFT
31 R.Somu 55 M AGN RFT
32 P.Ramalakshmi 61 F AGN RFT
33 S.Laskhmi 40 F AGN RFT
34 V.Pongodi 45 F AGN 1 RFT
35 Neelamegham 75 M AGN 1 RFT
36 Velu 65 M AGN RFT
37 Andibalan 58 M AGN HP RFT
38 Jeyaprakash 50 M AGN RFT
39 Alaghan 65 M AGN RFT
40 Prabha 45 F 1 RFT
41 Thangachamy 65 M AGN RFT
42 Malaichami 65 M AGN RFT
43 Sarasu 56 F AGN RFT
44 Jeyabalan 60 M AGN RFT
45 Mookan 65 M AGN HP RFT
46 D.Palaniammal 70 F AGN RFT
47 Selvam 65 M AGN RFT
MASTER CHART
Cutaneous
Manifestation
y
Manifestati
on Nerve Thickening
Senory
Imparment Motor Palsy
Skin 
Biopsy
48 K.Nallandu 63 F AGN RFT
49 M.Seva 55 F AGN 1 RFT
50 Veeramal 43 F AK RFT
51 Ramaya 50 M AGN 1 RFT
52 R.Palani 42 M AGN RFT
53 Pichi 55 F AGN RFT
54 A.Andiappan 50 M AGN RFT
55 A.Alaghappan 50 M AGN RFT
56 Andiappan 50 M AGN RFT
57 Karupannan 65 M AGN RFT
58 Nallian 65 M AGN RFT
59 Veeran 55 M AGN RFT
60 Malaichami 50 M AGN RFT
61 Palaniandi 55 M AGN HP RFT
62 Alagappan 50 M AGN HP 1 RFT
63 Chinnan 52 M AGN RFT
64 Andiappan 55 M AGN RFT
65 Kasipathi 45 M AGN RFT
66 Veeraie 65 F AGN RFT
67 Krishnan 36 M KN RFT
68 Samayan 60 M KN RFT
69 Duraisami 50 M KN RFT
70 Rathinam 76 M KN RFT
71 RAJA 50 M AGN RFT
KEY FOR MASTER CHART 
SEX 
 M – Male 
 F – Female 
PLACE 
 AGN – Alanganallur 
CUTANEOUS LESIONS 
 HP – Hypopigmented Patch 
 EP – Erythematous Patch 
 S – Single 
 M - Multiple 
SITE 
 R – Right 
L - Left 
 FM – Forearm 
 UL – Upper Limb 
 LL – Lower Limb 
 UB – Upper Back 
 
DURATION 
 m – Month 
 y – Year 
INFILTRATION 
 1 – Present 
LOSS OF SWEAT OR NOT 
 1 – Present 
NERVE THICKENING 
 LPN – Lateral Popliteal Nerve 
 UN – Ulnar Nerve 
 U – Unilateral 
 B – Bilateral 
SENSORY IMPAIRMENT , MOTOR PALSY, SKIN BIOPSY, TROPHIC 
ULCER 
 1 – Finding Present 
DIAGNOSIS 
 TT – Tuberculoid  
 BL – Borderline Lepromatous 
 BT – Borderline Tuberculoid 
 T1 – Type 1 Reaction 
 Old Case – On Treatment 
 RFT – Released From Treatment 
NEW CASE 
 PB – Paucibacillary 
 MB - Multibacillary 
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